FierceBiotech 3 feb 2026 Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b
Endpoints News 3 feb 2026 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News 3 feb 2026 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
FierceBiotech 21 ene 2026 Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
FierceBiotech 20 ene 2026 Pfizer pens $530M deal to use Novavax's vaccine adjuvant tech on 2 programs
BioPharma Dive 12 ene 2026 JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year
FierceBiotech 9 ene 2026 Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Endpoints News 8 ene 2026 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work